Intensive glycaemic therapy for type 1 diabetes cuts risk of death

January 6, 2015 4:42 PM

4 0

Intensive glycaemic therapy for type 1 diabetes cuts risk of death

Intensive glycaemic therapy for patients recently diagnosed with type 1 diabetes resulted in a decreased rate of long-term mortality compared with patients given conventional therapy, according to research published on 6 January 2014 in JAMA[1].

Researchers tracked the mortality and specific causes of death of 1,441 patients with type 1 diabetes mellitus for an average of 27 years until the end of 2012. The patients were originally recruited to the Diabetics Control and Complications Trial (DCCT), which took place between 1983 and 1993.

Read more

To category page

Loading...